The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Venker Eric

Reporting owner CIK 0001801917 · Chief Executive Officer · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Venker EricVenker EricVenker Eric · October 1, 2026 · Exercise / conversion · Common StockVenker Eric · September 30, 2026 · Exercise / conversion · Common SharesVenker Eric · December 24, 2025 · Exercise / conversion · Common SharesVenker Eric · December 23, 2025 · Exercise / conversion · Common SharesVenker Eric · December 9, 2025 · Exercise / conversion · Common SharesVenker Eric · November 7, 2025 · Exercise / conversion · Common SharesVenker Eric · October 17, 2025 · Exercise / conversion · Common SharesVenker Eric · October 16, 2025 · Exercise / conversion · Common SharesVenker Eric · October 15, 2025 · Exercise / conversion · Common SharesVenker Eric · October 13, 2025 · Exercise / conversion · Common SharesVenker Eric · October 9, 2025 · Exercise / conversion · Common SharesOct 9, 2025Oct 1, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

11 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 1, 2026Immunovant, Inc.Common StockVenker EricExercise / conversion
Sep 30, 2026Roivant Sciences Ltd.Common SharesVenker EricExercise / conversion
Dec 24, 2025Roivant Sciences Ltd.Common SharesVenker EricExercise / conversion
Dec 23, 2025Roivant Sciences Ltd.Common SharesVenker EricExercise / conversion
Dec 9, 2025Roivant Sciences Ltd.Common SharesVenker EricExercise / conversion
Nov 7, 2025Roivant Sciences Ltd.Common SharesVenker EricExercise / conversion
Oct 17, 2025Roivant Sciences Ltd.Common SharesVenker EricExercise / conversion
Oct 16, 2025Roivant Sciences Ltd.Common SharesVenker EricExercise / conversion
Oct 15, 2025Roivant Sciences Ltd.Common SharesVenker EricExercise / conversion
Oct 13, 2025Roivant Sciences Ltd.Common SharesVenker EricExercise / conversion
Oct 9, 2025Roivant Sciences Ltd.Common SharesVenker EricExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Immunovant, Inc.IMVT · company listings
Venker EricChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M92,18714.46 *Value: 1,333,024.02Currency not specifiedView ↗
Trade: Roivant Sciences Ltd.ROIV · company listings
Venker EricPresident & Immunovant CEO
Exercise / conversionCommon SharesNon-derivative security · Code M200,0003.85Value: 770,000Currency not specifiedView ↗
Trade: Roivant Sciences Ltd.ROIV · company listings
Venker EricPresident & Immunovant CEO
Exercise / conversionCommon SharesNon-derivative security · Code M117,8483.85Value: 453,714.8Currency not specifiedView ↗
Trade: Roivant Sciences Ltd.ROIV · company listings
Venker EricPresident & Immunovant CEO
Exercise / conversionCommon SharesNon-derivative security · Code M313,8413.85Value: 1,208,287.85Currency not specifiedView ↗
Trade: Roivant Sciences Ltd.ROIV · company listings
Venker EricPresident & Immunovant CEO
Exercise / conversionCommon SharesNon-derivative security · Code M200,0003.85Value: 770,000Currency not specifiedView ↗
Trade: Roivant Sciences Ltd.ROIV · company listings
Venker EricPresident & Immunovant CEO
Exercise / conversionCommon SharesNon-derivative security · Code M200,0003.85Value: 770,000Currency not specifiedView ↗
Trade: Roivant Sciences Ltd.ROIV · company listings
Venker EricPresident & Immunovant CEO
Exercise / conversionCommon SharesNon-derivative security · Code M118,41815.85Value: 1,876,925.3Currency not specifiedView ↗
Trade: Roivant Sciences Ltd.ROIV · company listings
Venker EricPresident & Immunovant CEO
Exercise / conversionCommon SharesNon-derivative security · Code M318,28215.85Value: 5,044,769.7Currency not specifiedView ↗
Trade: Roivant Sciences Ltd.ROIV · company listings
Venker EricPresident & Immunovant CEO
Exercise / conversionCommon SharesNon-derivative security · Code M414,68315.85Value: 6,572,725.55Currency not specifiedView ↗
Trade: Roivant Sciences Ltd.ROIV · company listings
Venker EricPresident & Immunovant CEO
Exercise / conversionCommon SharesNon-derivative security · Code M20,72715.85Value: 328,522.95Currency not specifiedView ↗
Trade: Roivant Sciences Ltd.ROIV · company listings
Venker EricPresident & Immunovant CEO
Exercise / conversionCommon SharesNon-derivative security · Code M104,94015.85Value: 1,663,299Currency not specifiedView ↗